Xyzal and Lovaza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xyzal and Lovaza. Common interactions include osteopenia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Xyzal and Lovaza have. It is created by eHealthMe based on reports of 95 people who take Xyzal and Lovaza from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 28, 2023

95 people who take Xyzal and Lovaza together, and have interactions are studied.

What is Xyzal?

Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 17,855 Xyzal users for its effectiveness, alternative drugs and more.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 16,913 Lovaza users for its effectiveness, alternative drugs and more.

Number of Xyzal and Lovaza reports submitted per year:

Common Xyzal and Lovaza drug interactions by gender *:

female:

Osteopenia
Osteoporosis
Protein total increased
Fatigue
Renal failure
Cataract
Convulsion
Diabetes mellitus
Diverticulum
Gastrointestinal ulcer

male:

Chronic kidney disease
Renal failure
Drug ineffective
Drug intolerance
Hypotension
Libido decreased
Mood altered
Pain
Productive cough
Suicidal ideation

Common Xyzal and Lovaza drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Urticaria

20-29:

n/a

30-39:

n/a

40-49:

Osteopenia
Osteoporosis
Ankle fracture
Arthritis
Diabetes mellitus
Foot fracture
Hip fracture
Liver disorder
Lower limb fracture
Menstruation irregular

50-59:

Back pain
Chronic kidney disease
Hospitalisation
Hypokalaemia
Nephrolithiasis
Weight increased
Asthma
Dizziness
Drug intolerance
Fatigue

60+:

Chronic kidney disease
Renal failure
Dizziness
Dyspepsia
Headache
Pain
Hypersensitivity
Hypotension
Injection site haematoma
Injection site pain

Common conditions people have *:

High Blood Pressure: 19 people, 20.00%
Hypersensitivity: 18 people, 18.95%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 17.89%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 16.84%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 15.79%
Pain: 14 people, 14.74%
Asthma: 13 people, 13.68%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 12.63%
Depression: 11 people, 11.58%
Infection: 8 people, 8.42%

* Approximation only. Some reports may have incomplete information.

Do you take Xyzal and Lovaza?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Xyzal (17,855 reports)
Lovaza (16,913 reports)